Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 67296-1440

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-1440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg/300 mg (30 Tablet Bottle))

Package Label-principal Display Panel (200 mg/300 mg (30 Tablet Bottle))
The text describes a medication that consists of film-coated tablets with emuricitabine and tenofovir disoproxil fumarate as active ingredients. The dosage instructions and administration details are mentioned in the package insert. The medication should be stored at a temperature range of 20° to 25°C. Aurobindo Pharma USA, Inc is the distributor of the said medication. The text also mentions some additional details such as the NDC code, dosage guidance, and a barcode for printing purposes.*
FDA Label Image

Chemical Structure-1 (Emtriteno Str1)

FDA Label Image

Chemical Structure-2 (Emtriteno Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.